Stock listing
NASDAQ:SESN Sesen Bio Inc Stock
Follow Sesen Bio Inc into a list and get an email when it puts out news.
Delisted NASDAQ:SESN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:SESN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Sesen Bio Inc on 6ix
- Decks
- 34 decks · latest Apr 10, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Carisma Therapeutics — Technical Presentation (April 2024) | Technical | 9 slides | Apr 10, 2024 |
| Carisma Therapeutics — CAR-TCR Summit 2023 | Conference | 20 slides | Sep 1, 2023 |
| Merger or Acquisition (February 2023) | Merger or acquisition | 17 slides | Feb 2, 2023 |
| Merger or Acquisition (December 2022) | Merger or acquisition | 24 slides | Dec 12, 2022 |
| Merger or Acquisition (September 2022) | Merger or acquisition | 26 slides | Sep 27, 2022 |
| Technical Presentation (September 2021) | Technical | 17 slides | Sep 10, 2021 |
| Jefferies Virtual Healthcare Conference 2021 | Conference | 74 slides | Jun 4, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 76 slides | May 10, 2021 |
| Corporate Update (March 2021) | Corporate update | 84 slides | Mar 15, 2021 |
| Investor Presentation (March 2021) | Investor deck | 82 slides | Mar 1, 2021 |
All 34 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Richard F Fitzgerald Other companies: 22nd Century Group, Inc (Chief Financial Officer · Nov 15, 2021 – Mar 21, 2022 · Past); Nauticus Robotics, Inc. (Chief Financial Officer · Jul 14, 2021 – Jul 14, 2021 · Past); Immunome, Inc. (Chief Financial Officer · Oct 1, 2020 – Oct 1, 2020 · Past); Eleven Biotherapeutics Inc (Chief Financial Officer · Oct 20, 2017 – Apr 9, 2018 · Past); PAVmed Inc. (CFO and Secretary · Jan 29, 2016 – Jun 1, 2016 · Past); TechPrecision Corporation (Chief Financial Officer · Jun 13, 2013 – Aug 12, 2015 · Past) | Chief Financial Officer · Feb 21, 2019 – Feb 21, 2019 · Past |
| Jason Keyes Other companies: BlossomHill Therapeutics, Inc. (Executive Vice President and Chief Financial Officer · Since at least Aug 6, 2026); Actuate Therapeutics, Inc. (Director · Since at least Aug 12, 2024); Equillium, Inc. (Chief Financial Officer · Dec 10, 2020 – Feb 14, 2025 · Past) | Director · May 3, 2021 – Jun 22, 2022 · Past |
| Peter Honig Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past); Orexigen Therapeutics Inc (Director · Jun 5, 2013 – Jul 14, 2017 · Past) | Director · Jul 20, 2021 – Jun 22, 2022 · Past |
| Stephen A Hurly Other companies: LAVA Therapeutics NV (Chief Executive Officer, Director · Since at least Jan 1, 2025); Eleven Biotherapeutics Inc (President and CEO, Director · Sep 20, 2016 – Apr 9, 2018 · Past) | President and CEO, Director · Jun 12, 2018 – Jun 12, 2018 · Past |
| Abbie Celniker Other companies: Eleven Biotherapeutics Inc (Director · Jun 15, 2016 – May 19, 2017 · Past) | Director · Jun 12, 2018 – Jun 12, 2018 · Past |
| Mark Sullivan Other companies: Definium Therapeutics, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Apr 13, 2023) | General Counsel & Secretary · Aug 1, 2019 – Mar 2, 2023 · Past |
| Glen C MacDonald | Chief Technology Officer · Feb 19, 2021 – Mar 2, 2023 · Past |
| Kirstin Anderson | Principal Accounting Officer · Aug 26, 2019 – Feb 19, 2021 · Past |
| Leslie Dan | Director · Jun 12, 2018 – Jun 19, 2019 · Past |
| Thomas R Cannell | President and CEO, Director · Feb 13, 2020 – Mar 2, 2023 · Past |
Log in to ask 6ix AI your own questions about Sesen Bio Inc.